Skip to content

Effect of pneumoperitoneum-free laparoscopic radical hysterectomy on prognosis for patients with early stage cervical cancer

Effect of pneumoperitoneum-free laparoscopic radical hysterectomy on prognosis for patients with early stage cervical cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035515
Enrollment
Unknown
Registered
2020-08-13
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Group 1:pneumoperitoneum-free laparoscopic radical hysterectomy
Group 2:laparoscopic radical hysterectomy
Group 3:abdominal radical hysterectomy

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Early stage cervical cancer (stage IA1 with lymphovascular space invasion, IA2, IB1); 2. Cervical squamous cell, cervical adenosquamous cancer or cervical adenocarcinoma; 3. Aged <=65 years; 4. Without preoperative radiotherapy or chemotherapy; 5. All patients sign informed consent, have good compliance to coporate follow-up. (Note: The measurement of the maximum diameter of cervical lesions is subject to preoperative MRI)

Exclusion criteria

Exclusion criteria: 1. Patients with poor general conditions and severe medical complications that are difficult to tolerate surgical treatment; 2. Patients who have received pelvic/abdominal radiotherapy or chemotherapy previously; 3. Pregnant; 4. Patients with other gynecological malignant diseases, such as ovarian tumor; 5. CT, MRI or PET indicated extracervical metastasis; 6. Unable or unwilling to sign the informed consent, unable or unwilling to comply with the research requirement;

Design outcomes

Secondary

MeasureTime frame
intraoperative and postoperative complications;Quality of life;

Primary

MeasureTime frame
Recurrence-free survival;Overall survival;

Countries

China

Contacts

Public ContactKeqin Hua

Obstetrics and Gynecology Hospital of Fudan University

huakeqin@126.com15921515900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026